Alcohol Consumption Impacts Liver Fibrosis Progression in Minority of Patients Screened for Hepatitis C at Drug Treatment Centers
Patients with active HCV infections at DTC have an increased risk for ALD compared to patients without HCV. High-risk alcohol consumption is present in a minority of patients aggravating fibrosis. These results suggest that HCV treatment should not be delayed at DTC regardless of alcohol consumption.
Authors
- María Jesús Medina Alonso
- Alberto Hernández‐Bustabad (ORCID: https://orcid.org/0000-0003-1949-1295)
- Fernando Gutiérrez Hidalgo (ORCID: https://orcid.org/0000-0001-9885-0094)
- Luz Goretti Santiago Gutiérrez
- Victor Pérez Pérez
- ESTHER CARBALLO
- Julia Nazco
- Dalia Morales‐Arráez (ORCID: https://orcid.org/0000-0002-4615-0560)
- Manuel Hernández‐Guerra (ORCID: https://orcid.org/0000-0002-3478-9981)
- Ruth Tramontani Ramos (ORCID: https://orcid.org/0000-0001-8202-4855)
- Felícitas Díaz-Flores
- Zaida Ramos-Marrero
Institutions
- Universidad de La Laguna (ES)
- Hospital Universitario de Canarias (ES)
Publication Details
- Journal
- Substance Use Research and Treatment
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1177/29768357251347821
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III
- European Regional Development Fund